Introducing innovation and integrated care solutions in Europe’s health and social care systems through cross-border value-based innovation procurement.
The EURIPHI (European Innovative Procurement of Health Innovation) Coordinating and Supporting Action (CSA) ended in June 2020. The project aimed to build out a common vision on the use of Value Based Innovation Procurement as a strategic tool fostering innovation. Since June 2020, actions have been put in place to ensure the sustainability of the results achieved during the project.
The EURIPHI CSA fostered a change in procurement practices leading to a value-based approach resulting in most economic advantageous tendering (MEAT). The time for change in procurement practices is now, responding to the common needs of health systems throughout Europe. The objectives of EURIPHI project were three-fold and were designed to build a foundation for future EU cross-border Value Based PPI/PCP.
Establish a sustainable Community of Practice using innovative procurement methods and develop legal guidance for efficient cross-border, value driven procurement with localised decision making.
Adapt the existing tools, perform market consultations and deploy cross-border Value Based PPI/PCP testing as learning cases in the field of rapid diagnostics for infectious diseases and, new models of patient-centred integrated care.
Develop an EURIPHI Health & Social Care Regions Network, including representatives of (regional) health authorities, policymakers, and payers who, in collaboration with other key stakeholders, identified priority investment areas and fostered the deployment of Value Based PPI/PCP.
EURIPHI Community of Practice and Regions Network
The EURIPHI Value Based Procurement Community of Practice gathers public procurers, representatives of purchasing organisations and health and social care providers interested in sharing experiences on Value Based Innovation Procurement.
The EURIPHI Health & Social Care Regions Network gathers representatives of regional health and social care authorities, with an ability to impact decision in investments on innovation by deploying PPI/PCP.